The use of propionyl L-carnitine in combination with acetyl L-carnitine, or one of their pharmaceutically acceptable salts, is disclosed for the preparation of a medicament, or of a nutritional supplement, for the prevention and/or treatment of the disorders of the male andropause caused by ageing or by chemical or surgical castration.

 
Web www.patentalert.com

< Method for inhibition of necrosis induced by neurotrophin

< Quinoline derivatives as nk-2 and nk-3 receptor antagonists

> Benzazole analogues and uses thereof

> Method of ameliorating or abrogating the effects of a neurodegenerative disorder, such as amyotrophic lateral sclerosis (ALS), by using a HDAC inhibiting agent
~ 00272